AzTrials
AzTrials

StrokeNCT06806397

Study of Hemodynamic Markers of Upper Extremity Motor Dysfunction in Stroke Patients Using Functional Near Infrared Spectroscopy (fNIRS)

An observational study of Stroke and Stroke with Hemiparesis, run by Skolkovo Institute of Science and Technology at 2 sites in Russia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of the study was to explore potential pathways for recovery and adaptation of the motor cortex by examining cerebral blood flow characteristics and hemodynamic markers analyzed by functional near-infrared spectroscopy (fNIRS) in patients with hemiparesis after stroke. Read more about this study

Who is it for?
Ages 35 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Stroke, Stroke with Hemiparesis, Stroke, Ischemic
What is being tested?
Stimulus response task
How many people
40 participants
Where
2 sitesRussia
Study dates
26 Jun 2024to Apr 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients undergoing rehabilitation at the Federal center of brain research and neurotechnologies, FMBA, Moscow, Russia

Who may be able to join

  • 1. Availability of signed written informed consent. 3. Absence of somatic and psychiatric diseases (more details in the exclusion criteria) 4. Ability and willingness to comply with the requirements of this protocol.
  • Signed written informed consent.
  • People after the first acute cerebrovascular accident (CVA), early or late rehabilitation period.
  • The level of severity of paresis of the upper limb from 3 points to 0 (according to a 6-point neurological scale)
  • The minimum visual acuity is not lower than 0.2 on the Sivtsev scale.
  • The ability and willingness of the patient to comply with the requirements of this protocol.
  • Expressed patient motivation for rehabilitation.

Who cannot join

  • The presence of superficial injury of head (S00-S09 International Classification of Diseases 10 (ICD-10).
  • The presence of mental, behavioural disorders (F00-F99 ICD-10).
  • Drug addiction in the past or at the moment.
  • The presence of diseases of the nervous system (G00-G99 ICD-10).
  • . History of intracranial injury (S06 ICD-10) or stroke (I64 ICD-10).
  • The presence of somatoform disorders (F45 ICD-10).
Show all 29Show fewer
  • Any conditions that, in the opinion of the Investigator, meet the exclusion criteria
  • Presence of electrical and/or metallic implants or stimulants in the body (eg, implanted deep brain stimulation devices, pacemakers, hearing aids and cochlear implants, intracranial metal implants).
  • Pregnancy
  • The presence of malignant neoplasms (C00-C97 ICD-10).
  • For stroke patients:
  • Severe cognitive impairment (<10 points according to the Montreal Cognitive Assessment Scale).
  • Hamilton score above 18 points.
  • The score on the Rankin scale is above 4 points.
  • Associated neurological disorders that cause decreased muscle strength or increased muscle tone in the upper limbs (eg, cerebral palsy, brain damage from trauma) or stiffness (eg, Parkinson's disease, contracture).
  • Late stages of arthritis or clinically significant limitation of passive range of motion in any of the joints studied in the study due to other reasons.
  • The absence of a part of the upper limb due to amputation caused by various reasons.
  • Any medical condition, including mental illness or epilepsy, that may affect the interpretation of study results, study conduct, or patient safety.
  • Alcohol abuse, medical marijuana use, or recreational drug use in the 12 months prior to Visit 1.
  • Use of experimental drugs or medical devices within 30 days prior to Visit 1.
  • Lack of ability to follow study procedures, in the opinion of the investigator.
  • The severity of the patient's condition according to the neurological or somatic status, which does not allow full rehabilitation.
  • Severe visual disturbances, minimal visual acuity less than 0.2 Sivtsev visual acuity table.
  • Unstable angina and/or heart attack within the previous month
  • Repeated stroke.
  • Severe unilateral spatial neglect.
  • Uncontrolled arterial hypertension
  • Ataxia
  • All forms of epilepsy

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Daria Petrova, PhD contact

+7 915 420 5113

d.petrova@skoltech.ru

Russia2 sites, 1 recruiting
  • Skolkovo Institute of Science and Technology (Skoltech)

    Moscow

    Completed
  • Skolkovo Institute of Science and Technology (Skoltech)

    Moscow

    Recruiting

Other trials in Russia

About this study

Official title: Studying the Mechanisms of Visual-motor Transformation to Find Neurophysiological Markers of Altered Functions of Cortical Motor Circuits in Patients with Neurological Disorders and Developing Technologies for Their Rehabilitation.

The aim of the study was to explore potential pathways for recovery and adaptation of the motor cortex by examining cerebral blood flow characteristics and hemodynamic markers analyzed by functional near-infrared spectroscopy (fNIRS) in patients with hemiparesis after stroke. Participants in the study performed a simple stimulus-response task several times with one healthy and one paralyzed limb at different stages of basic rehabilitation. A group of healthy, age-matched volunteers participated in the same experiment to verify the stroke-related changes. The researchers recorded fNIRS signals, muscle activity using electromyography, and heart activity using electrocardiography.

Read the detailed description

The study included 40 participants, divided into two groups: individuals with a history of stroke-related hemiparesis and a matched healthy control group.Participants were instructed to perform a stimulus-response task designed to assess reaction speed.During the task, they positioned their hands within a designated box equipped with two buttons corresponding to left and right responses. A visual stimulus, presented via LEDs located above the buttons, served as the response target. A flash of a stimulus required participants to respond by extending their fingers to press the corresponding button. If limb paresis prevented a full button press, participants were instructed to form an intention to move and attempt the task to the best of their ability.

Neurophysiological data acquisition. Functional near-infrared spectroscopy (fNIRS) data were acquired using a combined NIRSport 16x16 and NIRSport 8x8 system (NIRx Medizintechnik GmbH, Berlin, Germany).Twenty-four sources and 24 detectors were placed over the sensorimotor area and adjacent regions, forming 76 source-detector pairs to ensure comprehensive cortical coverage. The light sources were activated synchronously, resulting in a sampling rate of 13.56 Hz. In addition, surface electromyography (EMG), electrocardiography (ECG), and scalp electroencephalography (EEG) were recorded using the NVX-36 electroencephalograph (ISS, Zelenograd, Russia). EMG activity was recorded from the extensor digitorum communis muscle of both hands using a bipolar belly-tendon montage. ECG was recorded by 1st standard bipolar montage with electrode placed on both wrists. EEG was recorded with 6 electrodes placed at 'FCC3', 'FCC4', 'CCP3', 'CCP4', 'FCC5', 'A1', 'FCC6', 'A2' according to the standard "10-05" montage. The experimental protocol was completed within two weeks for each participant. There were six sessions (3 at the beginning of rehabilitation and 3 before discharge). Each session lasted a maximum of one hour. Before the experimental session, each patient's motor abilities were tested using the Action Research Arm Test (ARAT) and the Fugl-Meyer Assessment (FMA) scale.

Being tested
Stimulus response task
Keywords
stroke, hemiparesis, hemodynamics, fNIRS, restoration of motor function, Neurovascular coupling
Medical subject headings
Stroke, Ischemic Stroke, Paresis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stimulus response taskDiagnostic test

    Participants were tasked with performing a finger extension exercise that required pressing buttons in response to visual stimuli. In cases where physical movement was not possible, participants were instructed to imagine performing the task while focusing on their fingers.

Study groups in NCT06806397
Study groupRoleWhat they receive
Individuals after strokeNot described
Receives: Diagnostic Test: Stimulus response task
Healthy volunteersNot described
Receives: Diagnostic Test: Stimulus response task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hemodynamic changes after stroke

    In post-stroke subjects, an increase in blood flow and oxygenation was observed in sensorimotor cortical regions of both hemispheres during movement of the paretic limb. This observation may indicate that the healthy hemisphere contributes to the execution of movement.

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Feb 2025
  2. Study start26 Jun 2024
  3. Primary completion20 Jan 2025
  4. Study completionApr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06806397
Sponsor's protocol ID
Skoltech-CNBR7
Other IDs
21-75-30024
Status last verified
Jan 2025
First submitted
28 Jan 2025
Last updated
4 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Stroke with Hemiparesis, run by Skolkovo Institute of Science and Technology at 2 sites in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 29 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 4 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Daria Petrova, PhD (+7 915 420 5113, d.petrova@skoltech.ru), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hemodynamic changes after stroke (time frame: 14 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in